Emil von Behring
|Emil von Behring|
Emil Adolf von Behring
|Born||Adolf Emil Behring
15 March 1854
|Died||31 March 1917
|Notable students||Hans Schlossberger|
|Known for||Diphtheria antitoxin/serum|
|Notable awards||Nobel Prize in Physiology or Medicine (1901)|
Emil von Behring (Emil Adolf von Behring), as Emil Adolf Behring born (15 March 1854 – 31 March 1917) was a German physiologist who received the 1901 Nobel Prize in Physiology or Medicine, the first one awarded, for his discovery of a diphtheria antitoxin. He was widely known as a "saviour of children," as diphtheria formerly was a major cause of child death. He was ennobled in 1901 for services to medicine.
Between 1874 and 1878, he studied medicine at the Akademie für das militärärztliche Bildungswesen, Berlin. He was mainly a military doctor and then became Professor of Hygienics within the Faculty of Medicine at the University of Marburg (against the initial strenuous opposition of the faculty council), a position he would hold for the rest of his life. He and the pharmacologist Hans Horst Meyer had their laboratories in the same building, and Behring stimulated Meyer's interest in the mode of action of tetanus toxin.
Behring was the discoverer of diphtheria antitoxin in 1890 and attained a great reputation by that means and by his contributions to the study of immunity. He won the first Nobel Prize in Physiology or Medicine in 1901 for the development of serum therapies against diphtheria (which Kitasato Shibasaburo and Emile Roux also contributed to) and tetanus. The former had been a scourge of the population, especially children, whereas the other was a leading cause of death in wars, killing the wounded. He was elected a Foreign Honorary Member of the American Academy of Arts and Sciences in 1902. At the International Tuberculosis Congress in 1905 he announced that he had discovered "a substance proceeding from the virus of tuberculosis." This substance, which he designated "T C", plays the important part in the immunizing action of Professor Behring's "bovivaccine", which prevents bovine tuberculosis. He tried unsuccessfully to obtain a protective and therapeutic agent for humans.
He created an antitoxin.
Behring demonstrated that the injection of toxins was able to be transmitted to another animal by injections of a treated animal's blood serum and used as a means of effecting a cure.
Behring died at Marburg, Hessen-Nassau, on 31 March 1917. His name survived with the Dade Behring, organisation, at the time, the world's largest company dedicated solely to clinical diagnostics, (now part of the Siemens Healthcare Division) in CSL Behring a manufacturer of plasma-derived biotherapies, in Behringwerke AG in Marburg, in Novartis Behring and in the Emil von Behring Prize of the University of Marburg, the highest endowed medicine award in Germany.
Von Behring is believed to have cheated Paul Ehrlich out of recognition and financial reward in relation to collaborative research in diphtheria. The two men developed a diphtheria serum by repeatedly injecting the deadly toxin into a horse. The serum was used effectively during an epidemic in Germany. A chemical company preparing to undertake commercial production and marketing of the diphtheria serum offered a contract to both men, but von Behring maneuvered to claim all the considerable financial rewards for himself. To add insult to injury, only Behring received the first Nobel Prize in Medicine, in 1901, for his contributions.
In December 1896, Behring married the then eighteen-year-old Else Spinola, who was a daughter of Bernhard Spinola, the director of the Charité hospital in Berlin, and a Jewish-born mother who had converted to Christianity upon her marriage. They had six sons. They held their honeymoon at villa "Behring" on Capri 1897, where Behring owned a vacation home. In 1909–1911, the Russian writer Maxim Gorky lived at this villa.
- Die Blutserumtherapie (1892)
- Die Geschichte der Diphtherie (1893)
- Bekämpfung der Infektionskrankheiten (1894)
- Beiträge zur experimentellen Therapie (1906)
- E. v. Behring's Gesammelte Abhandlungen (1915) Digital edition by the University and State Library Düsseldorf
- The Immune System: In Defence of our Lives, nobelprize.org
- Legrum, Wolfgang; Al-Toma, Adnan J.; Netter, Karl J. (1992). 125 Jahre Pharmakologisches Institut der Philipps-Universität Marburg. Marburg: N. G. Elwert Verlag. ISBN 3770809858.
- "Book of Members, 1780–2010: Chapter B" (PDF). American Academy of Arts and Sciences. Retrieved 30 May 2011.
- Emil von Behring Serum Therapy in Therapeutics and Medical Science. Nobel Lecture, December 12, 1901. nobelprize.org
- Hewlett, Richard Tanner (1903). Serum therapy: bacterial therapeutics and vaccines. p. 3.
- Morton A. Meyers, M.D. (2007). Happy Accidents: Serendipity in Modern Medical Breakthroughs.
- Derek S. Linton, Emil von Behring: Infectious Disease, Immunology, Serum Therapy, American Philosophical Society, 2005, p. 198
- Kornelia Grundmann (3 December 2001). "Emil von Behring: The founder of serum therapy". The Nobel Foundation. Retrieved 2008-07-21.
- This article incorporates text from a publication now in the public domain: Gilman, D. C.; Thurston, H. T.; Moore, F., eds. (1905). "article name needed". New International Encyclopedia (1st ed.). New York: Dodd, Mead.
- Ulrike Enke: Salvatore dell'Infanzia Behring and Capri
|Wikimedia Commons has media related to Emil Adolf von Behring.|